OsteoCool RF Ablation System
The OsteoCool™ RF Ablation system is cooled radiofrequency (RF) ablation technology. It offers simultaneous, dual-probe capabilities for treating painful bone tumors.
OsteoCool RF Ablation delivers energy to the site consistently.
Bone is the third most common location where cancerous cells metastasize.1 The most common locations for bone metastases include the spine, pelvis, and hip.
Metastatic bone disease occurs in 60% to 80% of cancer patients, most frequently among patients with primary malignancies of the breast, prostate, liver, and lung.2
Bone metastases can affect quality of life, producing complications such as pain, fractures, and decreased mobility. In addition to these symptoms, they can cause mood changes such as depression and anxiety.3
Patients with metastatic bone cancer may be treated with conventional therapies such as opioids, chemotherapy, or radiation therapy for pain palliation. With OsteoCool RF Ablation, I can treat patients’ bone tumors when conventional therapies aren’t effective, are too slow acting, or cause unacceptable side effects.4Dr. Sandeep Bagla Interventional Radiologist Vascular Institute of Virginia, Woodbridge, VA
Coaxial, bipolar technology delivers RF energy to the site, and automatically moderates power to keep RF heating within the desired treatment range. This reduces risk of potential thermal damage to adjacent tissue.5
The active tip of the ablation probe is internally cooled with circulating water. RF energy heats the tissue while circulating water moderates the temperature close to the active tip. This combination:
The OsteoCool RF ablation probes are sterile and intended for single use.
The OsteoCool™ bone access kits are indicated for percutaneous access to bone.*
Kurup AN, Callstrom MR, J Vasc Interv Radiol. 2010; 21(8 Suppl):S242-S250.
Schulman KL, Kohles J. Economic burden of metastatic bone disease in the U.S. Cancer. 2007; 109(11):2334-2342.
Goetz et al. Percutaneous Image-Guided Radiofrequency Ablation of Painful Metastases Involving Bone: A Multicenter Study. J Clin Oncol. 2004;22(2):300-306.
Gangi et al. Image-Guided Ablation Therapy of Bone Tumors. Elsevier Inc., 2009.
Based on internal testing. Data on file.
See OsteoCool Indications for Use.